Annual Massey Research Retreat draws record turnout
On Friday, May 23, the annual Virginia Commonwealth University (VCU) Massey Cancer Center Research Retreat attracted more than 150 attendees to learn about the most promising cancer research being conducted at Massey and throughout VCU.
Clevenger invested inaugural chair
Charles V. Clevenger, M.D., Ph.D., Chair of the Department of Pathology, has been invested as the inaugural Carolyn Wingate Hyde Chair in Cancer Research.
Main Street Homes presents $30,000 to Massey
Main Street Homes, Richmond’s largest locally owned new home builder, presented $30,000 to VCU Massey Cancer Center. The check represents proceeds from the sale of a custom home built as part of a luxury home show benefiting Massey in September 2013. This was Massey’s first opportunity to partner with Main Street Homes.
The basics of bladder cancer
Did you know that bladder cancer is the fifth most common cancer in the United States? In fact, the American Cancer Society estimates there will be nearly 75,000 new cases of bladder cancer diagnosed this year. In this article, we’re going to discuss the risk factors, symptoms, early detection and treatment of bladder cancer.
Device found to reduce chemotherapy-induced pain
An estimated 30 to 40 percent of cancer patients treated with chemotherapy experience pain, according to the National Cancer Institute. Known as chemotherapy-induced peripheral neuropathy (CIPN), CIPN can produce sharp pains, numbness, tingling and or burning sensations in the hands and feet of cancer patients because of nerve damage caused by chemotherapy. However, a recent clinical trial utilizing a device first tested at VCU Massey Cancer Center provides further evidence that it can significantly reduce CIPN symptoms without the use of drugs or invasive treatments.